Consort Medical plc:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Consort Medical plc Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Drug Delivery Devices 11
3.1.1 Metered Dose Inhaler Devices 11
3.1.2 Needle Free Injections 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Bespak – Drug Delivery Device 14
5.2.1 Overview 14
5.2.2 Financials 14
5.2.3 Capital Expenditure 14
5.2.4 Market View 14
5.3 King Systems – Anaesthesia Products 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Capital Expenditure 14
5.3.4 Market View 14
5.4 Major Products and Services 15
5.4.1 Overview 15
6 History 16
7 SWOT Analysis 19
7.1 Overview 19
7.2 Consort Medical plc Strengths 20
7.2.1 Successful Integration of The Medical House 20
7.2.2 Focused Research and Development Activities 20
7.2.3 Geographical Diversity 20
7.2.4 Strong Liquidity Position 20
7.3 Consort Medical plc Weaknesses 21
7.3.1 Product Recalls 21
7.3.2 High Debt 21
7.4 Consort Medical plc Opportunities 22
7.4.1 Expansion in New Markets 22
7.4.2 Global Anesthesia and Respiratory Devices Market 22
7.4.3 Growing Aged Population 22
7.4.4 Emerging Inhaled Drug Delivery Market 23
7.5 Consort Medical plc Threats 24
7.5.1 Rapid Technological Changes 24
7.5.2 Stringent Government Regulations 24
7.5.3 Intense Competition 24
7.5.4 Industry Consolidation Challenges 24
8 Competitors 25
9 Competitive Landscape 26
9.1 Drug Delivery Devices (Metered Dose Inhaler Devices), Global, Market Share (%), 2011 26
9.2 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Region, Market Share (2011) 28
9.3 Consort Medical plc, Drug Delivery Devices (Metered Dose Inhaler Devices), by Country, Market Share (2011) 29
9.4 Drug Delivery Devices (Needle Free Injections), Global, Market Share (%), 2011 31
9.5 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Region, Market Share (2011) 32
9.6 Consort Medical plc, Drug Delivery Devices (Needle Free Injections), by Country, Market Share (2011) 33
9.7 Consort Medical plc, Drug Delivery Devices, Global, Category Revenue Share (2011) 35
9.8 Consort Medical plc, Asia-Pacific, Category Revenue Share (2011) 37
9.8.1 Consort Medical plc, Australia, Category Revenue Share (2011) 39
9.8.2 Consort Medical plc, China, Category Revenue Share (2011) 41
9.8.3 Consort Medical plc, Japan, Category Revenue Share (2011) 43
9.8.4 Consort Medical plc, Other Asia-Pacific, Category Revenue Share (2011) 45
9.9 Consort Medical plc, Europe, Category Revenue Share (2011) 46
9.9.1 Consort Medical plc, France, Category Revenue Share (2011) 48
9.9.2 Consort Medical plc, Germany, Category Revenue Share (2011) 50
9.9.3 Consort Medical plc, Italy, Category Revenue Share (2011) 52
9.9.4 Consort Medical plc, Spain, Category Revenue Share (2011) 54
9.9.5 Consort Medical plc, United Kingdom, Category Revenue Share (2011) 56
9.9.6 Consort Medical plc, Other Europe, Category Revenue Share (2011) 58
9.10 Consort Medical plc, Middle East and Africa, Category Revenue Share (2011) 60
9.11 Consort Medical plc, North America, Category Revenue Share (2011) 62
9.11.1 Consort Medical plc, Canada, Category Revenue Share (2011) 64
9.11.2 Consort Medical plc, United States, Category Revenue Share (2011) 66
9.12 Consort Medical plc, South and Central America, Category Revenue Share (2011) 68
9.12.1 Consort Medical plc, Brazil, Category Revenue Share (2011) 70
9.12.2 Consort Medical plc, Other South and Central America, Category Revenue Share (2011) 72
10 Key Employees 74
11 Key Employee Biographies 75
12 Company Statement 76
13 Locations And Subsidiaries 77
13.1 Head Office 77
13.2 Other Locations & Subsidiaries 77
14 Financial Deals Landscape 79
14.1 Consort Medical plc, Deals Volume Summary, 2007 to 2012 79
15 Consort Medical plc, Deals Summary By Region, 2007 to 2012 80
16 Consort Medical plc Detailed Deal Summary 82
16.1 Venture Financing 82
16.1.1 Atlas Genetics Raises $27 Million In Series B Financing 82
16.2 Partnerships 84
16.2.1 Consort Medical Enters Into Co-Development Agreement With Atlas Genetics 84
16.2.2 King Systems Enters Into Distribution Agreement With Beijing Gloryway Technology 85
16.2.3 Bespak Enters Into Co-Development Agreement With Zogenix 86
16.3 Acquisition 87
16.3.1 Ambu To Acquire King Systems From Consort Medical For Up To $170 Million 87
16.3.2 Consort Medical Completes The Acquisition Of Medical House 89
16.3.3 King Systems Acquires Majority Interest In Emergent Respiratory Products 91
17 Recent Developments 92
17.1 Strategy And Business Planning 92
17.1.1 Aug 03, 2006: Bespak To Withdraw From Consumer Dispensers Business 92
17.2 Financial Announcements 92
17.2.1 Dec 05, 2012: Consort Medical Reports Revenue Of £69.9m In H1 Fiscal 2013 92
17.2.2 Jul 28, 2011: Consort Medical Reports Total Revenues Of £132.4m In Fiscal 2011 93
17.2.3 Dec 02, 2010: Consort Medical Reports Total Revenues Of GBP69.6 Million In H1 Fiscal 2011 94
17.2.4 Jun 17, 2010: Consort Medical Reports Preliminary Fiscal 2010 Results 94
17.2.5 Dec 10, 2009: Consort Medical Reports Total Revenues Of GBP61.5 Million In H1 Fiscal 2010 95
17.2.6 Jun 24, 2009: Consort Medical Reports Preliminary Results For Fiscal 2009 97
17.2.7 Dec 11, 2008: Consort Medical Declares Interim Dividend 98
17.2.8 Dec 11, 2008: Consort Medical 1H Fiscal 2009 Results 98
17.2.9 Jan 18, 2007: Bespak Declares Interim Results 100
17.2.10 Nov 07, 2006: Bespak Sees To Beat Own Expectations 102
17.2.11 Jul 12, 2006: Bespak Declares 2006 Results 103
17.3 Corporate Communications 106
17.3.1 Dec 02, 2010: Consort Appoints Nick Higgins As Executive Director 106
17.3.2 May 21, 2010: Consort Medical Appoints Keyvan Djamarani As Group Director, Operations 106
17.3.3 Oct 13, 2009: Consort Medical Announces Departure Of Paul Boughton As Corporate Development Director 106
17.3.4 May 06, 2009: Consort Medical Appoints Dr William Jenkins As An Independent Non-Executive Director 107
17.3.5 Feb 13, 2009: Consort Medical Appoints New Chairman 107
17.3.6 Jun 24, 2008: Consort Medical Appoints Group Finance Director 108
17.3.7 Dec 05, 2007: Consort Medical Appoints CEO 108
17.3.8 Feb 16, 2007: Bespak Appoints Head Of Corporate Communications 108
17.3.9 Sep 28, 2006: Bespak To Hold Its AGM 109
17.3.10 Aug 31, 2006: Bespak Appoints Non-Executive Director 109
17.3.11 Jul 27, 2006: Bespak Appoints Group Finance Director 110
17.4 Product News 110
17.4.1 Oct 03, 2011: Bespak Wins Contract To Develop Unidose Nasal Drug Delivery Device 110
17.5 Other Significant Developments 111
17.5.1 May 03, 2007: Bespak Expects Strong Financials 111
17.5.2 Apr 03, 2007: Bespak To Raise Funds For The British Lung Foundation 111
18 Appendix 112
18.1 Research Methodology 113
18.2 Secondary Research 113
18.3 Primary Research 113
18.4 Models 114
18.5 Forecasts 114
18.6 Expert Panels 114
18.7 GlobalData Consulting 114
18.8 Currency Conversion 115
18.9 Contact Us 116
18.10 Disclaimer 116


【レポート販売概要】

■ タイトル:Consort Medical plc:市場シェア分析
■ 英文:Consort Medical plc Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160484
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。